Nuubo Revenue and Competitors
Estimated Revenue & Valuation
- Nuubo's estimated annual revenue is currently $10.3M per year.
- Nuubo's estimated revenue per employee is $251,000
Employee Data
- Nuubo has 41 Employees.
- Nuubo grew their employee count by 3% last year.
Nuubo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $70.5M | 281 | 5% | N/A | N/A |
#2 | $59.7M | 238 | 26% | N/A | N/A |
#3 | $21.3M | 85 | 0% | N/A | N/A |
#4 | $5.3M | 21 | 17% | N/A | N/A |
#5 | $10.3M | 41 | 3% | N/A | N/A |
#6 | $8M | 32 | 10% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $16.8M | 67 | 3% | N/A | N/A |
#9 | $26.1M | 104 | 12% | N/A | N/A |
#10 | $1.8M | 7 | 0% | N/A | N/A |
What Is Nuubo?
Nuubo envisions wireless health and remote monitoring of physiological parameters as a simple, transparent and non-intrusive experience that should be available to anyone, anywhere. Nuubo is a wearable wireless medical device company, with headquarters based in Madrid and R&D labs and manufacturing facilities in Valencia (Spain). The company designs, manufactures and sells a proprietary portfolio of innovative wearable wireless medical technologies for prevention, diagnosis and rehabilitation.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$10.3M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nuubo News
PC Based Electrocardiograph (ECG) Consumption Market Size, Share, Growth 2022-2029| Key Players NUUBO Smart Solutions Technologies, SL,...
... Philips Healthcare, Hill-Rom (Welch Allyn), Biotronik, OSI Systems (Spacelabs Healthcare), NUUBO Smart Solutions Technologies, Fukuda Denshi.
LG Electronics Inc. Lifesense LifeWatch. Medtronic NIKE Nuubo Omron Philips Samsung Sotera Wireless Stryker Corporation Virtual-Realties Limited
Other Companies in Madrid
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 41 | 41% | N/A |
#2 | $4.3M | 41 | 5% | N/A |
#3 | $4.8M | 41 | 41% | N/A |
#4 | $3.3M | 41 | -2% | N/A |
#5 | $8.9M | 41 | -11% | N/A |